|
|
||||||||
American Journal of Clinical Nutrition, Vol 51, 665-669, Copyright © 1990 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
PC Zemel, MB Zemel, M Urberg, FL Douglas, R Geiser and JR Sowers
Division of Endocrinology, Nutrition and Hypertension, Wayne State University, School of Medicine, Detroit, MI.
The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg aspartate (20 mmol elemental Mg twice daily) and six received placebo for 3 mo. In comparison with placebo treatment, magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism. These results demonstrate that in magnesium-repleted hypertensive subjects, magnesium supplementation does not affect blood pressure or lipids probably because magnesium has no effect on cellular cation metabolism in magnesium-replete individuals.
This article has been cited by other articles:
![]() |
Y. Kawano, H. Matsuoka, S. Takishita, and T. Omae Effects of Magnesium Supplementation in Hypertensive Patients : Assessment by Office, Home, and Ambulatory Blood Pressures Hypertension, August 1, 1998; 32(2): 260 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, W. C. Willett, A. Smith, L. E. Brown, B. Rosner, and T. J. Moore Effect on Blood Pressure of Potassium, Calcium, and Magnesium in Women With Low Habitual Intake Hypertension, January 1, 1998; 31(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, L. E. Brown, L. Appel, N. O. Borhani, D. Evans, and P. Whelton Combinations of Potassium, Calcium, and Magnesium Supplements in Hypertension Hypertension, December 1, 1995; 26(6): 950 - 956. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |